Piper Sandler analyst David Westenberg raised the firm’s price target on Labcorp (LH) to $240 from $235 following quarterly results. The firm remains on the sidelines with a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $289 from $282 at Baird
- Labcorp price target raised to $249 from $234 at Barclays
- Morning Movers: UPS ascends and Textron descends after quarterly reports
- Labcorp reports Q3 adjusted EPS $3.50, consensus $3.48
- Labcorp narrows FY24 adjusted EPS view to $14.30-$14.70 from $14.30-$14.90